Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

692
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
692
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

272
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
272

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway.

Drug design, development and therapy·2022
Same author

Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells.

OncoTargets and therapy·2020
Same author

Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2019
Same author

Pillar[5]arene-based diglycolamides for highly efficient separation of americium(III) and europium(III).

Dalton transactions (Cambridge, England : 2003)·2014
Same author

V3 stain-free workflow for a practical, convenient, and reliable total protein loading control in western blotting.

Journal of visualized experiments : JoVE·2014
Same author

Sorting and identification of side population cells in the human cervical cancer cell line HeLa.

Cancer cell international·2014

Related Experiment Video

Updated: Sep 25, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

A Transfer Learning Method for Detecting Alzheimer's Disease Based on Speech and Natural Language Processing.

Ning Liu1,2, Kexue Luo3, Zhenming Yuan4

  • 1School of Public Health, Hangzhou Normal University, Hangzhou, China.

Frontiers in Public Health
|May 2, 2022
PubMed
Summary

This study introduces a transfer learning model using speech and natural language processing for early Alzheimer's disease (AD) diagnosis. The model achieved 88% accuracy, improving prediction and reducing data requirements.

Keywords:
Alzheimer's diseaseBERTmachine learningnatural language processingtransfer learning

More Related Videos

Author Spotlight: Investigating the Impact of Emotional Prosodies on Voice Recognition and Perception
05:48

Author Spotlight: Investigating the Impact of Emotional Prosodies on Voice Recognition and Perception

Published on: August 9, 2024

1.7K
Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia
10:15

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

Published on: July 2, 2013

18.0K

Related Experiment Videos

Last Updated: Sep 25, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Author Spotlight: Investigating the Impact of Emotional Prosodies on Voice Recognition and Perception
05:48

Author Spotlight: Investigating the Impact of Emotional Prosodies on Voice Recognition and Perception

Published on: August 9, 2024

1.7K
Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia
10:15

Utilizing Repetitive Transcranial Magnetic Stimulation to Improve Language Function in Stroke Patients with Chronic Non-fluent Aphasia

Published on: July 2, 2013

18.0K

Area of Science:

  • Neuroscience
  • Computational Linguistics
  • Artificial Intelligence

Background:

  • Alzheimer's disease (AD) diagnosis remains challenging due to the lack of convenient and reliable detection methods.
  • Language changes in AD patients offer potential early diagnostic signals.
  • Limited large datasets hinder the application of complex deep learning models without feature engineering.

Purpose of the Study:

  • To develop a transfer learning model for early Alzheimer's disease diagnosis using speech and natural language processing (NLP).
  • To address the challenge of limited datasets in developing accurate AD detection models.
  • To leverage pre-trained language models for improved AD classification.

Main Methods:

  • Developed a transfer learning model by pre-training on large text datasets.
  • Utilized a distilled bidirectional encoder representation (distilBert) embedding.
  • Employed a logistic regression classifier for distinguishing AD patients from healthy controls (HC).
  • Evaluated the model on the Alzheimer's dementia recognition through spontaneous speech dataset.

Main Results:

  • The transfer learning model achieved an accuracy of 0.88.
  • This accuracy is comparable to the challenge's champion score and significantly outperforms the baseline (75%).
  • The model effectively distinguishes between AD patients and HC using spontaneous speech.

Conclusions:

  • Transfer learning significantly enhances Alzheimer's disease prediction accuracy.
  • This approach mitigates the need for extensive feature engineering.
  • The method effectively overcomes the limitations posed by small datasets in AD research.